It is noteworthy that an on-going clinical trial is investigating the association of inherited mutations in DNA repair genes, including BRCA1 and BRCA2, with PD-L1 expression and immune cells in breast cancer patients (ClinicalTrials.gov identifier: NCT03495544). The gene discussed is BRCA1; the disease is breast cancer.